Page last updated: 2024-11-05

tetraethyleneglycol dimethacrylate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tetraethyleneglycol dimethacrylate: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7980
CHEMBL ID3184138
SCHEMBL ID15895
MeSH IDM0259379

Synonyms (54)

Synonym
25101-32-0
sr 209
3,6,9-trioxaundecamethylene dimethacrylate
nsc 84253
brn 1803537
einecs 203-653-1
tgm 4
ccris 3435
2-propenoic acid, 2-methyl-, oxybis(2,1-ethanediyloxy-2,1-ethanediyl) ester
te egdma
tetraethylene glycol, dimethacrylate
tetraethyleneglycol dimethacrylate
methacrylic acid, oxybis(ethyleneoxyethylene) ester
tgm-4
109-17-1
nsc-84253
nsc84253
methacrylic acid, diester with tetraethylene glycol
tetraethylene glycol dimethacrylate
tetraethylene glycol dimethacrylate, technical, >=90% (gc)
2-[2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethoxy]ethyl 2-methylprop-2-enoate
NCGC00248228-01
2-propenoic acid, 2-methyl-, 1,1'-(oxybis(2,1-ethanediyloxy-2,1-ethanediyl)) ester
ct038eqf54 ,
unii-ct038eqf54
cas-109-17-1
dtxcid4024515
dtxsid6044515 ,
NCGC00254858-01
tox21_300956
((oxybis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-diyl) bis(2-methylacrylate)
transglutaminase 5
peg-4 dimethacrylate
peg-4 dimethacrylate [inci]
T3486
SCHEMBL15895
LTHJXDSHSVNJKG-UHFFFAOYSA-N
14-methyl-13-oxo-3,6,9,12-tetraoxapentadec-14-en-1-yl 2-methylacrylate #
CHEMBL3184138
tetraethylene glycol dimethacrylate(7 cp(25 degrees c))
J-002240
tetraethylene glycol dimethacrylate, contains <=1500 ppm mehq as inhibitor, 95%
mfcd00014932
mfcd00081877
tetraethylene glycol dimethacrylate, contains ~0.006% hydroquinone as stabilizer, 90%
tetraethylene glycol dimethacrylate (stabilized with hq)
F20349
tetraethylene glycol dimethacrylate; tegdma
Q27275744
D84708
((oxybis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-diyl)bis(2-methylacrylate)
tetraethyleneglycoldimethacrylate
BS-44110
peg bismethacrylate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency15.35530.000714.592883.7951AID1259392
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency52.95890.001022.650876.6163AID1224838; AID1224893
Histone H2A.xCricetulus griseus (Chinese hamster)Potency56.63630.039147.5451146.8240AID1224845
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency32.93840.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (5.26)18.2507
2000's11 (28.95)29.6817
2010's23 (60.53)24.3611
2020's2 (5.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.09 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index5.28 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index3.00 (0.95)

This Compound (22.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (10.00%)6.00%
Case Studies9 (22.50%)4.05%
Observational0 (0.00%)0.25%
Other27 (67.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]